Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
577
datasets available to search
ShareScore release 0.9.0
Dataset results
577 results for “Cholangiocarcinoma”
Evaluating a Community-Based Behaviour Change Communication Model to Prevent Cholangiocarcinoma in Khon Kaen, Thailand
ClinicalTrials.gov study NCT05321992. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Exploring the Efficacy and Safety of Tislelizumab in Combination With S-1 in the Treatment of Patients With Postoperative Recurrent High-risk Intrahepatic Cholangiocarcinoma
ClinicalTrials.gov study NCT06664021. IPD Sharing: NO. Countries: 1. Publications: 0.
FOLFOX-HAIC Combined With Donafenib and Pucotenlimab as First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma
ClinicalTrials.gov study NCT07353827. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Endobiliary Radiofrequency Ablation for Malignant Biliary Obstruction Due to Perihilar Cholangiocarcinoma
ClinicalTrials.gov study NCT05546372. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Next Generation Sequencing in Intrahepatic Cholangiocarcinoma
ClinicalTrials.gov study NCT02184871. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Role of Bile Duct Resection in Major Hepatectomy Due to Intrahepatic Cholangiocarcinoma
ClinicalTrials.gov study NCT01862276. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenvatinib, Tislelizumab Plus Gemcitabine and Cisplatin (GPLET) in Patients with Advanced Cholangiocarcinoma
ClinicalTrials.gov study NCT05532059. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Gemcitabine-Cisplatin-90Y TARE for Unresectable Intrahepatic Cholangiocarcinoma
ClinicalTrials.gov study NCT02512692. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Second-line Treatment With Apatinib in Patients With Advanced Intrahepatic Cholangiocarcinoma
ClinicalTrials.gov study NCT03251443. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced Intrahepatic Cholangiocarcinoma Patients With FGFR-2 Fusion or Rearrangement
ClinicalTrials.gov study NCT06728410. IPD Sharing: NO. Countries: 1. Publications: 0.
Low-dose Gemcitabine and Cisplatin and PD-1/PD-L1 Antibody Therapy in Intrahepatic Cholangiocarcinoma
ClinicalTrials.gov study NCT06567600. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Diagnostic Approach for Cholangiocarcinoma Using Liquid Bile Biopsy
ClinicalTrials.gov study NCT06416397. IPD Sharing: NO. Countries: 1. Publications: 0.
GEMOX Combined With Targeted Therapy and Immunotherapy for Patients With Advanced Cholangiocarcinoma
ClinicalTrials.gov study NCT05215665. IPD Sharing: Not stated. Countries: 1. Publications: 0.
SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma
ClinicalTrials.gov study NCT05568680. IPD Sharing: NO. Countries: 1. Publications: 0.
Toripalimab Combined With Gemcitabine and Cisplatin (GemCis) as Preoperative Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma
ClinicalTrials.gov study NCT06721286. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Hypofractionated Radiation Therapy and Bintrafusp Alfa for the Treatment of Advanced Intrahepatic Cholangiocarcinoma
ClinicalTrials.gov study NCT04708067. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cholangiocarcinoma
ClinicalTrials.gov study NCT02482454. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase I/II Safety and Efficacy Study of PCI of Gemcitabine and Chemotherapy in Patients With Cholangiocarcinomas
ClinicalTrials.gov study NCT01900158. IPD Sharing: NO. Countries: 4. Publications: 0.
HAIC Combined With Camrelizumab Plus Rivoceranib for Advanced Mixed Hepatocellular-cholangiocarcinoma (HCC-CCA)
ClinicalTrials.gov study NCT07105748. IPD Sharing: NO. Countries: 1. Publications: 0.
Precision Medicine in Patients With Unresectable CholAngiocarcinoma: RadioEmbolization and Combined Biological Therapy
ClinicalTrials.gov study NCT06375915. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.